
Network News

HEIDELBERG, Germany, April 15, 2025 – NEC Laboratories Europe and Data-Driven.AI are working together to enhance medical laboratory diagnosis and increase the effectiveness of preventive health measures and early clinical intervention to improve the well-being of patients. If detected early, many illnesses and diseases can be managed or resolved without serious complications. However, by the time recognizable symptoms present themselves, […]
read more
Helping children with cancer with flowers
From April 28 to May 24, you can once again buy and give flower creations throughout Germany for the benefit of children and young people with cancer. With its campaign “Blumen schenken. Hoffnung spenden.” (Give flowers. Spread hope.) the Hopp Children’s Cancer Center Heidelberg (KiTZ) wants to draw attention to the urgently needed research for […]
read more
Blenrep (belantamab mafodotin) combinations approved by UK MHRA in relapsed/refractory multiple myeloma
GSK plc (LSE/NYSE: GSK) today announced the authorisation of Blenrep by the Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Blenrep is approved for the treatment of adults with multiple myeloma in combination with bortezomib plus dexamethasone (BVd) in patients who have received at least one prior therapy, and in combination with pomalidomide plus dexamethasone (BPd) in […]
read more
BioMed X Launches XBridge Program to Support Biomedical Researchers Impacted by NIH Funding Gaps
Heidelberg, Germany, April 7th, 2025. BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of its XBridge Program, a fast-track initiative designed to support U.S.-based biomedical researchers impacted by the current NIH funding gaps, hiring freezes, and grant terminations. The program offers a pathway for affected principal investigators in all […]
read more
Booster for cellular immunotherapy: Immunologist Michel Sadelain awarded Meyenburg Prize
The 2023/24 Meyenburg Prize, endowed with 50,000 euros, goes to Michel Sadelain of Columbia University, New York. The physician and immunologist is considered one of the fathers of CAR-T cell therapy. This cellular immunotherapy can be used to effectively treat certain blood cancers, even in advanced stages. The Meyenburg Prize will be awarded on Wednesday, […]
read more
Heinz Maier-Leibnitz Prize for Lukas Bunse
Germany’s most important award for young scientists honors the development of immunotherapies against malignant brain tumors. Using immune cells to fight brain tumors – that is the goal of Lukas Bunse, who is this year’s recipient of the Heinz Maier-Leibnitz Prize from the German Research Foundation (DFG). The physician and scientist is being honored for […]
read more
Batene: Energy boost for batteries
An electric car costs more than a comparable combustion engine because the battery is so expensive. And hardly any model gets as far on one charge as an average car on one tank of gas. Batene GmbH, a spin-off from the Max Planck Institute for Medical Research, wants to change this. The start-up is developing […]
read more
Robot navigates precisely to changes in the lungs
One of the most modern methods for diagnosing lung cancer is now available in the Thorax Clinic at Heidelberg University Hospital – robot-assisted bronchoscopy. With the steerable robotic catheter, small and unfavorably located abnormalities in the lung tissue can be reached more easily than before. The clinic is therefore ideally equipped for the start of […]
read more
Otto Warburg Medal 2025 goes to Matthias Hentze
In recognition of his fundamental contributions to the understanding of gene regulation by RNA-binding proteins and the identification of RNA-binding proteins, Prof. Dr. Matthias Hentze is awarded the Otto Warburg Medal 2025 of the Society for Biochemistry and Molecular Biology. More Information in German below. Otto-Warburg-Medaille 2025 geht an Matthias Hentze In Anerkennung seiner fundamentalen […]
read more